Lecanemab Homecare Service

A Tender Notice
by UNIVERSITY COLLEGE LONDON HOSPITALS NHS FT

Source
Find a Tender
Type
Contract (Services)
Duration
23.5 month
Value
£0-£816K
Sector
HEALTH
Published
19 Feb 2025
Delivery
To 16 Mar 2027 (est.)
Deadline
26 Mar 2025 00:00

Concepts

Location

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

Direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only.

Total Quantity or Scope

The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service. … The requirement is for a private homecare provider situated in the UK to provide this service.

CPV Codes

  • 85149000 - Pharmacy services

Indicators

  • This is a one-off contract (no recurrence)
  • Renewals are not available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains